Drug Good Manufacturing Practices (GMP) Compliance Seminar

In these unprecedented times, the pharmaceutical industry is playing an essential role for the U.S. consumer. Never before have more questions been raised regarding Good Manufacturing Practices (GMPs), so we are offering our Drug Good Manufacturing Practices (GMP) Compliance Seminar course virtually.

GMPs, dictated in 21 CFR 210, Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Drugs, have been in place for over a decade. Even with the Food and Drug Administration’s (FDA) efforts to ensure consistent manufacturing to established product specifications, industry confusion with the basic tenets of the regulation result in numerous FDA observations and Warning Letters. A thorough understanding of 21 CFR 210, as well as other statutory requirements is critical for compliance and safety for the consumer, both of which are required for the success of a company.

EAS Consulting Group Drug GMP Seminar helps firms prepare for FDA enforcement by facilitating an understanding of compliance requirements for responsibilities of domestic and foreign firms who manufacture, label, pack or hold pharmaceuticals for sale in the United States, including those involved with the testing, quality control and distribution of drugs.

Instructed by two cGMP experts with 30+ years combined industry experience this intensive training program will help your firm stay on top of cGMP requirements.